Riskpilot← Back to searchSign inGet full accessNova Health Group AB
ABActiveOrg 5593618332Narvavägen 12 1trActivities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 202220-49 employees
Revenue 2024
SEK 8,3M
EBITDA margin
3.9%
Equity ratio
48.2%
Financial strength
Net profit 2024
SEK 233K
| Revenue | SEK 8,3M | — |
| EBITDA | SEK 321K | — |
| Net profit | SEK 233K | — |
| Total assets | SEK 3,4M | +136% |
| Equity | SEK 1,6M | +14% |
| Employees | — | — |
Legal name
Nova Health Group AB
Org number
5593618332
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
24 januari 2022
Share capital
SEK 32 960
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva vård och utredning inom psykiatri och psykologi. Företaget ska även bedriva konsultation inom organisation, ledarskap och utbildning i psykiatri och psykologi och därmed förenlig verksamhet.
Address
Narvavägen 12 1tr
Email
lukas@novapsykiatri.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | — | 8 323 |
| Staff expenses | — | — | −3 669 |
| EBITDA | — | — | 321 |
| Depreciation & amort. | −0 | — | — |
| EBIT | 0 | 0 | 321 |
| Net financials | — | — | 6 |
| Profit before tax | 0 | 0 | 327 |
| Tax | −0 | — | −94 |
| Net profit | 0 | 0 | 233 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 25 | 1 428 | 3 367 |
| Equity | 25 | 1 428 | 1 624 |
| Long-term debt | 0 | — | 500 |
| Short-term debt | 0 | — | 1 243 |
| Total debt | — | — | 1 743 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20222024
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20222024
Return on equity
14.4%
This company
18.4%
Market median
+22% vs market
20222024
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20222024
Asset turnover
2.47×
This company
1.12×
Market median
+121% vs market
20222024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
LA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nova Health Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christoffer Michael Murath | Deputy Chief Executive Officer | 0 companies |
| Lukas Alf Gustav Levay | Chief Executive Officer | 0 companies |
| Robert Levay | Chairman | 0 companies |